Dr Andrew Alan Toogood

Consultant Endocrinologist

MB ChB (1987 Manchester) MRCP (1991 RCP London) MD (2002 Manchester) FRCP (2007 RCP London)

Professional Membership

  • Society for Endocrinology

  • The Endocrine Society (North America)

  • Childhood Cancer and Leukaemia Group

  • Royal College of Physicians, London

Clinical Interests

  • Endocrine disorders excluding diabetes mellitus

  • Pituitary disorders including pituitary tumours

  • Growth hormone deficiency

  • Acromegaly

  • Raised prolactin levels

  • Cushing’s syndrome

  • Hypopituitarism (pituitary hormone deficiencies)

  • Adrenal disorders

  • Impaired fertility

  • Thyroid dysfunction

  • Hormone disorders in young adults and Turner’s syndrome

  • Long-term complications of cancer treatment - this covers a wide range of possible problems caused by cancer treatment including endocrine dysfunct

Call 0808 101 0337


Personal profile

After completing my general medical training at Blackpool Victoria Hospital and Withington Hospital in Manchester I embarked upon my specialist training in endocrinology. I worked as a lecturer in medicine at the University of Sheffield with Professor Tony Weetmanfrom February 1992 until May 1993. I undertook research for my MD with Professor Stephen Shalet at the Christie Hospital in Manchester where I developed an interest in growth hormone deficiency and the late effects of cancer treatment until February 1997.

I undertook my professional training in the North West of England before going to the University of Virginia in March 1998 where I worked with Dr Michael Thorner as a post-doctoral fellow for two years. On my return to the UK I came to Birmingham to complete my specialist training.

I have worked at University Hospitals Birmingham as a consultant physician and endocrinologist since February 2002. I hold honorary contracts at the University of Birmingham and Birmingham Children’s Hospital. In addition to a general I run specialist clinics for patients with pituitary disease, late effects of cancer treatment, Turner’s syndrome, thyroid disease and for young adults with endocrine disorders. I also run transition clinics at Birmingham Children’s Hospital.

I have been a member of the Clinical Committee of the Society for Endocrinology for six years and Programme Advisor to the Committee for the last three years. I am a National Advisor to the National Cancer Survivorship Initiative and a member of the editorial board of Clinical Endocrinology.

Year qualified: